BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22180362)

  • 1. Effects of valproic acid (VPA) and levetiracetam (LEV) on proliferation, apoptosis and hormone secretion of the human choriocarcinoma BeWo cell line.
    Kwiecińska P; Wiśniewska J; Gregoraszczuk EŁ
    Pharmacol Rep; 2011; 63(5):1195-202. PubMed ID: 22180362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of levetiracetam and valproate on reproductive endocrine function studied in human ovarian follicular cells.
    Taubøll E; Gregoraszczuk EL; Wojtowicz AK; Milewicz T
    Epilepsia; 2009 Aug; 50(8):1868-74. PubMed ID: 19490055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of valproic acid and levetiracetam on apoptosis in the human ovarian cancer cell line OVCAR-3.
    Kwiecińska P; Taubøll E; Gregoraszczuk EL
    Pharmacol Rep; 2012; 64(3):603-14. PubMed ID: 22814014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells.
    Taubøll E; Gregoraszczuk EL; Tworzydø A; Wójtowicz AK; Ropstad E
    Epilepsia; 2006 Sep; 47(9):1580-3. PubMed ID: 16981877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.
    Zhang Q; Yang F; Hu Z; Zhang Z; Xu Q; Dante M; Wu H; Li Z; Li Q; Li K; Lu G
    Eur Radiol; 2017 May; 27(5):2137-2145. PubMed ID: 27553940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of valproic acid and levetiracetam on viability and cell cycle regulatory genes expression in the OVCAR-3 cell line.
    Kwiecińska P; Taubøll E; Gregoraszczuk EL
    Pharmacol Rep; 2012; 64(1):157-65. PubMed ID: 22580532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes.
    Li G; Nowak M; Bauer S; Schlegel K; Stei S; Allenhöfer L; Waschbisch A; Tackenberg B; Höllerhage M; Höglinger GU; Wegner S; Wang X; Oertel WH; Rosenow F; Hamer HM
    Seizure; 2013 Jul; 22(6):462-6. PubMed ID: 23639870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of valproate and levetiracetam on steroidogenesis in forskolin-stimulated H295R cells.
    von Krogh K; Harjen H; Almås C; Zimmer KE; Dahl E; Olsaker I; Taubøll E; Ropstad E; Verhaegen S
    Epilepsia; 2010 Nov; 51(11):2280-8. PubMed ID: 20726872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
    Brigo F; Bragazzi N; Nardone R; Trinka E
    Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of antiepileptic drugs on steroidogenesis in a human in vitro cell model.
    Gustavsen MW; von Krogh K; Taubøll E; Zimmer KE; Dahl E; Olsaker I; Ropstad E; Verhaegen S
    Acta Neurol Scand Suppl; 2009; (189):14-21. PubMed ID: 19566492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.
    Coupez R; Nicolas JM; Browne TR
    Epilepsia; 2003 Feb; 44(2):171-8. PubMed ID: 12558570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
    Tumay Y; Altun Y; Ekmekci K; Ozkul Y
    Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam.
    Goffin K; Bormans G; Casteels C; Bosier B; Lambert DM; Grachev ID; Van Paesschen W; Van Laere K
    Neuropharmacology; 2008 Jun; 54(7):1103-6. PubMed ID: 18423778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of four antiepileptic drugs in status epilepticus: experience from India.
    Misra UK; Kalita J
    Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.
    Nissen-Meyer LS; Svalheim S; Taubøll E; Reppe S; Lekva T; Solberg LB; Melhus G; Reinholt FP; Gjerstad L; Jemtland R
    Epilepsia; 2007 Oct; 48(10):1850-60. PubMed ID: 17634065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose intravenous administration of antiepileptic drugs induces rapid and reversible remodeling in the brain: Evidence from a voxel-based morphometry evaluation of valproate and levetiracetam in rhesus monkeys.
    Tang Y; Yu X; Zhang X; Xia W; Wu X; Zou X; Li H; Huang X; Stefan H; Chen Q; Gong Q; Zhou D
    Neuroscience; 2015 Sep; 303():595-603. PubMed ID: 26197226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells.
    Kwiecińska P; Wróbel A; Taubøll E; Gregoraszczuk EŁ
    Toxicol Lett; 2014 Jan; 224(2):225-32. PubMed ID: 24200999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.